Premium
Prohibitin interacts with phosphatidylinositol 3,4,5‐triphosphate (PIP3) and modulates insulin signaling
Author(s) -
Ande Sudharsana Rao,
Mishra Suresh
Publication year - 2010
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.24.1_supplement.848.1
Subject(s) - prohibitin , phosphorylation , tyrosine phosphorylation , phosphatidylinositol , microbiology and biotechnology , insulin receptor , signal transduction , protein kinase b , chemistry , biology , mitochondrion , insulin , endocrinology , insulin resistance
Mitochondrial protein prohibitin (PHB) is known to associate with the plasma membrane of various cell types. However, biological function of plasma membrane associated PHB is not known. Recently we have shown that PHB undergoes tyrosine phosphorylation in response to insulin and here we report that PHB interacts with phosphatidylinositol 3,4,5‐triphosphate (PIP3). Furthermore, we demonstrate that over expression of PHB attenuates insulin signaling downstream of phosphatidylinositol 3 (PI3) kinase. This effect was not observed with over expression of tyrosine phosphorylation site mutant‐PHB suggesting a role for tyrosine phosphorylation of PHB in this process. Interestingly phosphorylation of PHB by Akt attenuates its interaction with PIP3 and enhances insulin signaling. Thus, phosphorylation of PHB and its interaction with PIP3 may be a part of the regulatory mechanisms that is involved in the modulation of insulin signaling. We speculate that phosphorylation of PHB may serve as a general mechanism in the regulation of PI3 kinase signaling including growth factors and immune receptor signaling. This work was made possible by financial support from Manitoba Health Research Council (MHRC) and Winnipeg Health Sciences Centre Foundation to SM and MHRC postdoctoral fellowship to SRA.